Neogen (NEOG) Competitors $8.45 -0.41 (-4.63%) Closing price 04:00 PM EasternExtended Trading$8.46 +0.01 (+0.07%) As of 05:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NEOG vs. MMSI, ICUI, HAE, XRAY, QDEL, STAA, CERS, OSUR, ANIK, and UTMDShould you be buying Neogen stock or one of its competitors? The main competitors of Neogen include Merit Medical Systems (MMSI), ICU Medical (ICUI), Haemonetics (HAE), DENTSPLY SIRONA (XRAY), QuidelOrtho (QDEL), STAAR Surgical (STAA), Cerus (CERS), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), and Utah Medical Products (UTMD). These companies are all part of the "health care supplies" industry. Neogen vs. Merit Medical Systems ICU Medical Haemonetics DENTSPLY SIRONA QuidelOrtho STAAR Surgical Cerus OraSure Technologies Anika Therapeutics Utah Medical Products Neogen (NASDAQ:NEOG) and Merit Medical Systems (NASDAQ:MMSI) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, dividends, earnings, valuation, profitability, community ranking, risk and institutional ownership. Which has more risk and volatility, NEOG or MMSI? Neogen has a beta of 1.27, indicating that its share price is 27% more volatile than the S&P 500. Comparatively, Merit Medical Systems has a beta of 0.91, indicating that its share price is 9% less volatile than the S&P 500. Do analysts prefer NEOG or MMSI? Neogen currently has a consensus target price of $14.00, indicating a potential upside of 65.68%. Merit Medical Systems has a consensus target price of $110.78, indicating a potential upside of 5.76%. Given Neogen's higher probable upside, research analysts clearly believe Neogen is more favorable than Merit Medical Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Neogen 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Merit Medical Systems 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has stronger valuation and earnings, NEOG or MMSI? Merit Medical Systems has higher revenue and earnings than Neogen. Neogen is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeogen$913.83M2.01-$9.42M-$2.19-3.86Merit Medical Systems$1.36B4.54$94.41M$2.0351.60 Does the media prefer NEOG or MMSI? In the previous week, Merit Medical Systems had 14 more articles in the media than Neogen. MarketBeat recorded 21 mentions for Merit Medical Systems and 7 mentions for Neogen. Merit Medical Systems' average media sentiment score of 0.54 beat Neogen's score of 0.41 indicating that Merit Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Neogen 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Merit Medical Systems 10 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Does the MarketBeat Community favor NEOG or MMSI? Merit Medical Systems received 115 more outperform votes than Neogen when rated by MarketBeat users. Likewise, 69.91% of users gave Merit Medical Systems an outperform vote while only 56.58% of users gave Neogen an outperform vote. CompanyUnderperformOutperformNeogenOutperform Votes33156.58% Underperform Votes25443.42% Merit Medical SystemsOutperform Votes44669.91% Underperform Votes19230.09% Is NEOG or MMSI more profitable? Merit Medical Systems has a net margin of 9.05% compared to Neogen's net margin of -52.12%. Merit Medical Systems' return on equity of 15.61% beat Neogen's return on equity.Company Net Margins Return on Equity Return on Assets Neogen-52.12% 2.89% 1.98% Merit Medical Systems 9.05%15.61%8.38% Do insiders and institutionals believe in NEOG or MMSI? 96.7% of Neogen shares are owned by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are owned by institutional investors. 1.1% of Neogen shares are owned by insiders. Comparatively, 3.7% of Merit Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. SummaryMerit Medical Systems beats Neogen on 17 of the 19 factors compared between the two stocks. Remove Ads Get Neogen News Delivered to You Automatically Sign up to receive the latest news and ratings for NEOG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NEOG vs. The Competition Export to ExcelMetricNeogenDiagnostic substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.83B$2.46B$5.68B$8.32BDividend YieldN/A0.70%4.55%4.02%P/E Ratio-3.865.5724.5519.25Price / Sales2.0152.02395.7294.09Price / Cash9.8015.7538.1634.64Price / Book0.583.067.064.46Net Income-$9.42M-$65.73M$3.19B$247.07M7 Day Performance-9.14%-1.63%1.49%3.05%1 Month Performance-17.96%-7.49%5.87%-2.85%1 Year Performance-44.37%-17.20%14.94%4.63% Neogen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NEOGNeogen3.2014 of 5 stars$8.45-4.6%$14.00+65.7%-41.7%$1.83B$913.83M-3.862,110MMSIMerit Medical Systems3.4611 of 5 stars$100.68+1.8%$110.78+10.0%+44.8%$5.92B$1.36B49.356,950ICUIICU Medical4.4285 of 5 stars$149.11+3.9%$168.67+13.1%+52.7%$3.66B$2.38B-32.6314,000Positive NewsHAEHaemonetics4.6056 of 5 stars$64.84-1.0%$101.67+56.8%-19.6%$3.26B$1.37B25.533,657Positive NewsXRAYDENTSPLY SIRONA4.9241 of 5 stars$15.59+0.2%$23.33+49.7%-51.8%$3.10B$3.79B-7.5315,000Analyst RevisionQDELQuidelOrtho4.4505 of 5 stars$36.23+0.3%$51.20+41.3%-22.0%$2.44B$2.78B-1.207,100Positive NewsGap DownSTAASTAAR Surgical4.4009 of 5 stars$17.65+3.5%$26.86+52.2%-51.9%$870.34M$313.90M-43.041,115CERSCerus2.2993 of 5 stars$1.45-0.3%$4.00+176.8%-16.1%$268.47M$180.27M-13.14290OSUROraSure Technologies4.6569 of 5 stars$3.59+2.1%$5.50+53.4%-42.1%$268.16M$185.83M23.90840Buyback AnnouncementNews CoverageANIKAnika Therapeutics3.7396 of 5 stars$16.17+1.6%$22.00+36.1%-39.2%$236.75M$119.91M-2.43300UTMDUtah Medical Products3.5865 of 5 stars$58.05+1.3%N/A-16.8%$196.91M$40.90M14.70180News CoveragePositive News Remove Ads Related Companies and Tools Related Companies MMSI Competitors ICUI Competitors HAE Competitors XRAY Competitors QDEL Competitors STAA Competitors CERS Competitors OSUR Competitors ANIK Competitors UTMD Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NEOG) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neogen Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.